Female fertility preservation: A Clinical perspective

Mary Ellen Pavone*, Rafael Confino, Marissa Steinberg

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


For patients with cancer, preserving the ability to start a family at a time of their choosing is especially important and may influence decisions pertaining to cancer treatment. For other women who have delayed childbearing for personal or professional reasons, fertility preservation offers the possibility of having a biological child regardless of age. Though these women may be interested in or benefit from fertility preservation, fertility preservation services remain underutilized. While embryo and oocyte cryopreservation remain the standard strategies for female fertility preservation recommended by the American Society of Reproductive Medicine, the American Society of Clinical Oncology and the European Society of Medical Oncology, other strategies (e.g. pharmacological protection of the ovaries and ovarian tissue cryopreservation) are the subject of increasing research. This review will present new data that have become-available over the past few years pertaining to all available methods of fertility preservation.

Original languageEnglish (US)
Pages (from-to)458-465
Number of pages8
JournalMinerva Ginecologica
Issue number4
StatePublished - Aug 2016


  • Drug therapy
  • Fertility preservation
  • Neoplasms
  • Ovarian induction

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Female fertility preservation: A Clinical perspective'. Together they form a unique fingerprint.

Cite this